PT82515B - Processo para a preparacao de composicoes farmaceuticas contendo antagonistas de dopamina - Google Patents

Processo para a preparacao de composicoes farmaceuticas contendo antagonistas de dopamina

Info

Publication number
PT82515B
PT82515B PT82515A PT8251586A PT82515B PT 82515 B PT82515 B PT 82515B PT 82515 A PT82515 A PT 82515A PT 8251586 A PT8251586 A PT 8251586A PT 82515 B PT82515 B PT 82515B
Authority
PT
Portugal
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
dopamine antagonists
containing dopamine
Prior art date
Application number
PT82515A
Other languages
English (en)
Other versions
PT82515A (en
Inventor
Chrles Andrew Dackis
Mark Steven Gold
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT82515A publication Critical patent/PT82515A/pt
Publication of PT82515B publication Critical patent/PT82515B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT82515A 1985-05-06 1986-05-05 Processo para a preparacao de composicoes farmaceuticas contendo antagonistas de dopamina PT82515B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73110285A 1985-05-06 1985-05-06
US79118885A 1985-10-25 1985-10-25

Publications (2)

Publication Number Publication Date
PT82515A PT82515A (en) 1986-06-01
PT82515B true PT82515B (pt) 1988-10-14

Family

ID=27112170

Family Applications (1)

Application Number Title Priority Date Filing Date
PT82515A PT82515B (pt) 1985-05-06 1986-05-05 Processo para a preparacao de composicoes farmaceuticas contendo antagonistas de dopamina

Country Status (15)

Country Link
EP (1) EP0204954B1 (pt)
JP (1) JPS61293929A (pt)
AT (1) ATE78395T1 (pt)
AU (1) AU591120B2 (pt)
CA (1) CA1277914C (pt)
DE (2) DE3615190A1 (pt)
DK (1) DK167172B1 (pt)
FR (1) FR2587213B1 (pt)
GR (1) GR861128B (pt)
HU (1) HU197512B (pt)
IE (1) IE58884B1 (pt)
IL (1) IL78689A (pt)
IT (1) IT1203782B (pt)
NZ (1) NZ216050A (pt)
PT (1) PT82515B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814521A1 (de) * 1987-05-07 1988-11-17 Sandoz Ag Neue anwendung von dopaminrezeptor-agonisten
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
WO1991001732A1 (en) * 1989-08-03 1991-02-21 The United States Of America, Represented By The Secretary, United States Department Of Commerce Slowly dissociating (tight binding) dopamine, serotonin or norepinephrine reuptake inhibitors as ***e, amphetamine and phencyclidine antagonists
US6623752B1 (en) 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
DE19626621A1 (de) * 1996-07-02 1998-01-08 Hexal Ag Pflaster zur transdermalen Anwendung von Pergolid
US6517812B1 (en) 1997-09-24 2003-02-11 The General Hospital Corporation Inhibition of psychostimulant-induced and nicotine-induced craving
WO2019091870A1 (en) * 2017-11-08 2019-05-16 4P-Pharma Stimulant abuse-deterrent compositions
EP4316482A1 (en) * 2022-08-01 2024-02-07 4P-Pharma Levodopa for preventing addiction

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3995058A (en) * 1973-12-12 1976-11-30 Miles Laboratories, Inc. Treatment of ethanol withdrawal symptoms with levodopa

Also Published As

Publication number Publication date
EP0204954A3 (en) 1989-11-08
DE3686097T2 (de) 1993-01-07
NZ216050A (en) 1989-08-29
HUT40915A (en) 1987-03-30
AU591120B2 (en) 1989-11-30
AU5710986A (en) 1986-11-13
DK207086A (da) 1986-11-07
DE3686097D1 (de) 1992-08-27
JPH0569093B2 (pt) 1993-09-30
FR2587213B1 (fr) 1990-06-08
DK167172B1 (da) 1993-09-13
DE3615190A1 (de) 1987-05-21
CA1277914C (en) 1990-12-18
HU197512B (en) 1989-04-28
IE58884B1 (en) 1993-12-01
GR861128B (en) 1986-08-26
IL78689A0 (en) 1986-08-31
DK207086D0 (da) 1986-05-05
JPS61293929A (ja) 1986-12-24
FR2587213A1 (fr) 1987-03-20
IT8647977A0 (it) 1986-05-05
EP0204954A2 (en) 1986-12-17
EP0204954B1 (en) 1992-07-22
IE861189L (en) 1986-11-06
PT82515A (en) 1986-06-01
ATE78395T1 (de) 1992-08-15
IT1203782B (it) 1989-02-23
IL78689A (en) 1990-09-17

Similar Documents

Publication Publication Date Title
PT87958A (pt) Processo para a preparacao de composicoes farmaceuticas, contendo antagonistas 5ht-3
PT87259A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 17-cetoesteroides apropriadas para o tratamento e a profilaxia de infeccoes retrovirais
PT88047A (pt) Processo para a preparacao de prodrogas para agonistas muscarinicos oxadiazolicos
BR8806789A (pt) Processo para a preparacao de um polibuteno
PT88612A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um agente anti-calculo dental
DE3670359D1 (de) Einrichtung zum zufuehren von schmiermittel.
BR8803525A (pt) Composicao,composto e processo para a producao de um composto
PT88225A (pt) Processo para a preparacao de formulacoes farmaceuticas contendo di-hidropiridinas
DK314887D0 (da) Kompleksforbindelser, farmaceutiske midler med indhold heraf samt fremgangsmaade til fremstilling heraf
BR8704266A (pt) Processo para a preparacao de silanas contendo halogenio
PT88614A (pt) Processo para a preparacao de antagonistas do factor activador de plaquetas di-hidropiridinicos
PT82515B (pt) Processo para a preparacao de composicoes farmaceuticas contendo antagonistas de dopamina
PT88682A (pt) A process for the preparation of pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
BR8702906A (pt) Processo para preparacao de compostos e composicao herbicida
PT89085A (pt) Processo para a preparacao de alpha-heterociclil(contendo azoto)-etanolaminas uteis como agonistas beta-adrenergicos
PT84065B (pt) Processo para a preparacao de compostos polifluoroalquiltio-metilicos utilizaveis como agentes tensioactivos ou precursores destes ultimos
BR8806001A (pt) Processo para producao de composto e composicao inseticida
BR8804788A (pt) Composicao,aplicacao e processo para a preparacao de compostos
PT86964A (pt) Process for the preparation of a fungicidal composition containing 1,10-phenantrolines
PT89291A (pt) Processo para a preparacao de compostos de acidos 1-benzo-oxacicloalquil-piridinocarboxilicos hidrogenados
IT1208537B (it) Processo per la preparazione dell'isosorbide-5-monoidrato.
PT82117B (pt) Processo para a preparacao de composicoes farmaceuticas contendo 3-ariloxiazetidinocarboxamidas utilizaveis como agentes anticonvulsivantes e antiepilepticos
BR8803622A (pt) Processo para a preparacao de um composto e composicao inseticida
BR8806291A (pt) Processo para a preparacao de um composto de chumbo
PT82690B (pt) Processo para a preparacao de composicoes terapeuticas contendo derivados carboxi-azetidina

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19950930